Reviva Pharmaceuticals Holdings (RVPH) Assets (2018 - 2026)
Reviva Pharmaceuticals Holdings (RVPH) recorded Assets of $21.14 million in Q2 2026, up 81.7% from $11.63 million a year earlier but down 10.3% from the prior quarter.
Powered by 
Analysis
Reviva Pharmaceuticals Holdings (RVPH) Assets (2018 - 2026) Analysis & Trends
At the end of FY2025, Reviva Pharmaceuticals Holdings reported Assets of $15.92 million, up 2.7% from FY2024.
- Annual Assets has a five-year compound annual growth rate of 12.7% (FY2020 to FY2025).
- Across earlier years, Assets came in at $15.5 million in FY2024 (-34.6%), $23.7 million in FY2023 (+25.2%) and $18.92 million in FY2022.
- Quarterly Assets has ranged from $5.39 million in Q3 2023 to $33.89 million in Q3 2021 over the past five years.
- On a year-over-year basis, Assets has increased for five consecutive quarters, with growth averaging 51.1% over the last eight quarters.
- Peak year-over-year performance for Assets in the last five years was growth of 279.5% in Q1 2022, against a decline of 77.6% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $23.56 million (Q1 2026), $15.92 million (Q4 2025) and $14.33 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Reviva Pharmaceuticals Holdings | 6.16 Mn | 6.16 Mn | - | 21.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.14 Mn |
| Mar 31, 2026 | 23.56 Mn |
| Dec 31, 2025 | 15.92 Mn |
| Sep 30, 2025 | 14.33 Mn |
| Jun 30, 2025 | 11.63 Mn |
| Mar 31, 2025 | 7.08 Mn |
| Dec 31, 2024 | 15.50 Mn |
| Sep 30, 2024 | 7.63 Mn |
| Jun 30, 2024 | 8.05 Mn |
| Mar 31, 2024 | 13.50 Mn |
| Dec 31, 2023 | 23.70 Mn |
| Sep 30, 2023 | 5.39 Mn |
| Jun 30, 2023 | 11.84 Mn |
| Mar 31, 2023 | 12.90 Mn |
| Dec 31, 2022 | 18.92 Mn |
| Sep 30, 2022 | 24.04 Mn |
| Jun 30, 2022 | 20.64 Mn |
| Mar 31, 2022 | 25.27 Mn |
| Dec 31, 2021 | 31.40 Mn |
| Sep 30, 2021 | 33.89 Mn |
API Access
Reviva Pharmaceuticals Holdings Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=RVPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "RVPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=RVPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();